NO995914L - Fremgangsmåte for å påvise risiko for trombose - Google Patents

Fremgangsmåte for å påvise risiko for trombose

Info

Publication number
NO995914L
NO995914L NO995914A NO995914A NO995914L NO 995914 L NO995914 L NO 995914L NO 995914 A NO995914 A NO 995914A NO 995914 A NO995914 A NO 995914A NO 995914 L NO995914 L NO 995914L
Authority
NO
Norway
Prior art keywords
thrombosis
risk
procedure
detecting
Prior art date
Application number
NO995914A
Other languages
English (en)
Other versions
NO995914D0 (no
Inventor
Michael John Morser
Mariko Nagashima
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO995914D0 publication Critical patent/NO995914D0/no
Publication of NO995914L publication Critical patent/NO995914L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO995914A 1997-06-03 1999-12-02 Fremgangsmåte for å påvise risiko for trombose NO995914L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/869,057 US5985562A (en) 1997-06-03 1997-06-03 Method of detecting thrombotic disease risk associated with plasma carboxypeptidase B polymorphisms
PCT/EP1998/003244 WO1998055645A1 (en) 1997-06-03 1998-06-02 Method of detecting thrombotic disease risk

Publications (2)

Publication Number Publication Date
NO995914D0 NO995914D0 (no) 1999-12-02
NO995914L true NO995914L (no) 1999-12-02

Family

ID=25352852

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995914A NO995914L (no) 1997-06-03 1999-12-02 Fremgangsmåte for å påvise risiko for trombose

Country Status (7)

Country Link
US (1) US5985562A (no)
EP (1) EP0998583A1 (no)
JP (1) JP2002502253A (no)
AU (1) AU736330B2 (no)
CA (1) CA2292764A1 (no)
NO (1) NO995914L (no)
WO (1) WO1998055645A1 (no)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7524934B2 (en) 1999-04-30 2009-04-28 Akira Matsumoto Human brain carboxypeptidase B antibodies

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6455294B1 (en) * 2001-03-21 2002-09-24 Applera Corporation Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
EP1383885A4 (en) * 2001-04-04 2005-11-30 American Diagnostica Inc METHOD FOR PRODUCING A STABILIZED THROMBIN-ACTIVATED FIBRINOLYSE INHIBITOR (TAFI) AND METHOD FOR THE USE THEREOF
GB0119269D0 (en) * 2001-08-08 2001-10-03 Astrazeneca Ab Method
EP1572906A4 (en) * 2002-03-04 2008-05-28 Bristol Myers Squibb Co NEW PAVIAN TAFI-CODING NUCLEIC ACID MOLECULES AND POLYPEPTIDES
AU2003262895A1 (en) * 2002-08-28 2004-03-19 Schering Aktiengesellschaft Carboxypeptidase b related polypeptides and methods of use
EP2204455A1 (en) * 2002-08-29 2010-07-07 American Diagnostica, Inc. Diagnostic assay for thrombin-activatable fibrinolysis inhibitor (TAFI)
SE0300971D0 (sv) * 2003-04-03 2003-04-03 Aga Ab Nitric oxide in treatment of inflammation
EP1531333A1 (en) * 2003-11-12 2005-05-18 Aventis Pharma Deutschland GmbH Method for the identification of a risk for a thrombogenic disorder by determining the TAFI-lle347 polymorphism
US7956743B2 (en) * 2007-06-29 2011-06-07 Oberthur Technologies Dual communication fob assembly comprising an insert within a base

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206161A (en) * 1991-02-01 1993-04-27 Genentech, Inc. Human plasma carboxypeptidase B

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7524934B2 (en) 1999-04-30 2009-04-28 Akira Matsumoto Human brain carboxypeptidase B antibodies
US7972771B2 (en) 1999-04-30 2011-07-05 Akira Matsumoto Human brain carboxypeptidase B

Also Published As

Publication number Publication date
CA2292764A1 (en) 1998-12-10
NO995914D0 (no) 1999-12-02
AU8335098A (en) 1998-12-21
US5985562A (en) 1999-11-16
WO1998055645A1 (en) 1998-12-10
AU736330B2 (en) 2001-07-26
EP0998583A1 (en) 2000-05-10
JP2002502253A (ja) 2002-01-22

Similar Documents

Publication Publication Date Title
DE69513300D1 (de) Bestimmungsverfahren
NO20002135D0 (no) Reflectometer
FI970468A0 (fi) Anvaendningspraoksberoende bokstavsmatning med nummertangenter
DE59611425D1 (de) Messfühler
DE69737746D1 (de) Ellipsometer
DE59810721D1 (de) Messfühler
PT958287E (pt) Inibidores de sulfamida-metaloprotease
DE69708751D1 (de) Messfühler
DE69718276D1 (de) Fixiergerät
ID18010A (id) Oligosakarida termodifikasi
DK0866843T3 (da) Desodoriseringsanlæg
DE69826837D1 (de) Inspektionsverfahren
FI974269A0 (fi) Radiosaendare-mottagarestruktur med tvao frekvensomraoden
DK78096A (da) Interferometer
NO995914L (no) Fremgangsmåte for å påvise risiko for trombose
FI962420A0 (fi) Foerstaerkare med laogbrus
FI972664A0 (fi) Foerseglad saeck med avluftning
FI974544A0 (fi) Anordning i en med manoeverplats foersedd lastkran
EP1007548A4 (en) THROMBIN INHIBITOR FROM TSE-TSE FLY
DE69709700D1 (de) Kontrastmittel
FI970405A0 (fi) Plattformad traeprodukt med skiktstruktur
NO964439L (no) Fôr
FI970017A0 (fi) Med lampeffekts maetning foersett reglerbart elektroniskt anslutningsorgan
FI972274A0 (fi) Foerfarande foer roekgasrening med snabba elektroner
FI972507A0 (fi) Graesklippningssax med skaft

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application